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The aim of this study was to look at the precision and accuracy of Point of Care glycosylated 
haemoglobin (POC-HbA1c) compared with laboratory-measured HbA1c (Lab-HbA1c). 
 
Methods 
Retrospective analysis of the charts of patients attended paediatric diabetes outpatient clinics during 
January 2018 to July 2019 in University Hospital Limerick (UHL) was conducted. 
Results 
In total, 163 patients’ charts were analysed, including 79 females (48.5%) and 84 males (51.5%). Lab-
HbA1c data were skewed positively, with a median of 67mmol/mol (IQR (60 to 76). POC- HbA1c data 
were also positively skewed, median of 61mmol/mol (IQR (55 to 68). The differences between POC- 
HbA1c and Lab-HbA1c was skewed negatively, median of -6mmol/mol (IQR (-9, -2). Gender, age and 
month of testing did not affect results.POC-HbA1c was more reliable and accurate when tested 
within 14 days of Lab-HbA1c. 
Conclusion 
POC-HbA1c was comparatively lowered as compared with Lab- HbA1c. The results for POC- HbA1c is 
most reliable compared with Lab-HbA1c if tested within14 days. 
 
Introduction  
HbA1c is a key indicator of glycaemic  control in patients with type 1 diabetes(T1D). Point of care 
HbA1c(POC-HbA1c) is commonly used as it is cost effective and results are immediately available in 
clinic. In this study, we sought to determine the precision and accuracy of POC-HbA1c compared 
with Lab-HbA1c in children with T1D attending a dedicated paediatric diabetes outpatients’ clinic 
(PDOPC).  
Methods 
This is a single centre retrospective observational study done, using data from a dedicated paediatric 
diabetic outpatients clinic in University hospital Limerick(UHL).The Primary outcome  of the study 
was to compare POC-HbA1c with Lab HbA1c and evaluate any reasons for differences between the 
two measures. All the patients less than 18 years old who attended PDOPC between January 2018 to 
July 2019 who had Lab-HbA1c and POC-HbA1c measured within 4 weeks and with diabetes duration 
longer than 6 months were eligible for study inclusion. Demographic data including age, gender, 
duration of diabetes and HBA1c were collected. Prospectively collected data in patient charts and on 
electronic databases were supplemented with retrospective data collection, when indicated. 
Patients who had their Lab- HbA1c done within 4 weeks of POC- HbA1c were enrolled because 
usually HBA1c gives you a reflection of diabetic control in last 4 weeks. Capillary blood HbA1c taken 
by a finger-prick blood sample was analysed on a DCA Vantage Analyzer (Siemens/Bayer, Germany) 
in the clinic at the time of outpatient visit. Venous whole blood samples were collected in containers 
with EDTA either on the same day or within 4 weeks either before or after the clinic attendance and 
were analyzed on Tosoh G8 HPLC analyzer. Patients who had only one reading of HbA1c were 




This report summarises the details of findings we found over 18 months in our hospital. We found 
point of care testing is equivalent to laboratory testing if they are done within certain time period. In 
total, 240 eligible patients attended PDOPC during the time frame; of which 163 patients were 
meeting the inclusion criteria (who had Lab-HbA1c and POC-HbA1c within 4 weeks’ time frame). 
Seventy-seven patients were excluded due to only one HbA1c recorded. Lab-HbA1c data was skewed 
positively, with a median of 67mmol/mol (IQR (60 to 76). POC-HbA1c data was also positively 
skewed with a median of 61mmol/mol (IQR (55 to 68). Nonparametric Wilcoxon signed rank test was 
significant at p<0.001 with a downwards trend.  
 
Analysis of demographics showed, 79 females (48.5%) and 84 males (51.5%). Only males 
demonstrated reduced Lab- HbA1c compared with POC-HbA1c (p<0.001). Median Lab-HbA1c 
68.5mmol/mol, IQR (63, 76.8) vs. median POC-HbA1c 62.5mmol/mol, IQR (56.3, 68.8) (p<0.001). 
Females only also showed a significant drop Lab-HbA1c compared with POC-HbA1c, median Lab-
HbA1c 65mmol/mol, IQR (59, 76) vs. median POC-HbA1c 59mmol/mol, IQR (54, 68) (p<0.001). 
 
The differences in readings had a negative skew with a median of -6 IQR (-9, -2). These differences 
were significantly different between the groups <14 days and >14 days between measures. Median 
<14 days -5mmol/mol IQR (-7, -2) vs. >14 days -8.5mmol/mol, IQR (-13.3, -2, p=0.001). Therefore, 
there were significantly greater differences (drops) in the >14 days group.  
 
When the differences were plotted against the child’s age in years. There was no statistically 
significant relationship was identified when the differences between Lab-HbA1C and POC-HbA1c 
were plotted against child’s age or gender.  
  
The drop in the measures was not significant when adjusted for gender and the time differences, 
using exploratory ANOVA to account for skewed distribution. Only the time by difference in measure 
interaction was significant p<0.001 with those having measures taken >14 days having a bigger 
difference between measures. Females tended to have lower average values when second measure 
taken >14 days and males tended to have higher values when the second measure taken >14 days. 
As all results of differences between measures were significant using the Wilcoxon signed rank test 
for time < 14 days and larger time spans and so the measures were not equivalent. In fact, for all 




This study clearly shows that in a population of paediatric patients with type 1 diabetes POC-HbA1c 
results are more reliable if they are done within 14 days of lab-HbA1c testing. To our knowledge, this 
is the first time that a comparison between POC-HbA1c and Lab-HbA1c has been studied in Irish 
population. The important finding in this study is that POC-HbA1c results are somewhat lower than 
Lab-HbA1c, but that the highest correlation between the two measurements was when the samples 
were drawn within 14 days of each other. There was no effect of gender, age and timing of testing 
during the whole year. There are several limitations of this study. It is a single centre study with 
relatively small sample size. This is a retrospective study as well. Ideally it should be prospective 
study and all patients should be undergoing both tests on the same day by a trained phlebotomist 
who is performing both tests consecutively. When we looked retrospectively, we found that many 
patients had not done both POC testing and laboratory testing limiting our sample size. In conclusion 
POC testing should be interpreted cautiously in clinical decision making and need more multicentre 
studies with large sample size with contemporaneous sampling and analysis using point of care and 
laboratory measures to draw definitive conclusion. 
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